711 related articles for article (PubMed ID: 1677361)
21. Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced GH secretion in acromegaly and type I diabetes mellitus.
Pietschmann P; Schernthaner G; Luger A
J Clin Endocrinol Metab; 1986 Aug; 63(2):389-93. PubMed ID: 3088023
[TBL] [Abstract][Full Text] [Related]
22. Atropine blockade of growth hormone (GH)-releasing hormone-induced GH secretion in man is not exerted at pituitary level.
Casanueva FF; Villanueva L; Dieguez C; Cabranes JA; Diaz Y; Szoke B; Scanlon MF; Schally AV; Fernandez-Cruz A
J Clin Endocrinol Metab; 1986 Jan; 62(1):186-91. PubMed ID: 3079600
[TBL] [Abstract][Full Text] [Related]
23. Sexual dimorphism of pyridostigmine potentiation of growth hormone (GH)-releasing hormone-induced GH release in humans.
Barbarino A; Corsello SM; Tofani A; Sciuto R; Della Casa S; Rota CA; Barini A
J Clin Endocrinol Metab; 1991 Jul; 73(1):75-8. PubMed ID: 2045474
[TBL] [Abstract][Full Text] [Related]
24. Effect of potentiation of cholinergic tone by pyridostigmine on the GH response to GHRH in elderly men.
Coiro V; Volpi R; Bertoni P; Finzi G; Marcato A; Caiazza A; Colla R; Giacalone G; Rossi G; Chiodera P
Gerontology; 1992; 38(4):217-22. PubMed ID: 1358762
[TBL] [Abstract][Full Text] [Related]
25. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man.
Arvat E; Di Vito L; Ramunni J; Gianotti L; Giordano R; Deghenghi R; Camanni F; Ghigo E
Clin Endocrinol (Oxf); 1997 Oct; 47(4):495-500. PubMed ID: 9404449
[TBL] [Abstract][Full Text] [Related]
26. Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release: studies in normal and acromegalic subjects.
Massara F; Ghigo E; Demislis K; Tangolo D; Mazza E; Locatelli V; Müller EE; Molinatti GM; Camanni F
Neuroendocrinology; 1986; 43(6):670-5. PubMed ID: 3093909
[TBL] [Abstract][Full Text] [Related]
27. Activation of cholinergic tone by pyridostigmine reverses the inhibitory effect of corticotropin-releasing hormone on the growth hormone-releasing hormone-induced growth hormone secretion.
Corsello SM; Tofani A; Della Casa S; Sciuto R; Rota CA; Colasanti S; Bini A; Barini A; Barbarino A
Acta Endocrinol (Copenh); 1992 Feb; 126(2):113-6. PubMed ID: 1543015
[TBL] [Abstract][Full Text] [Related]
28. Cholinergic modulation of growth hormone responses to growth hormone-releasing hormone in uraemic patients on peritoneal dialysis.
Díez JJ; Iglesias P; Selgas R; Bajo MA; Aguilera A
Clin Endocrinol (Oxf); 2000 Nov; 53(5):587-93. PubMed ID: 11106919
[TBL] [Abstract][Full Text] [Related]
29. Alpha 2-adrenergic control of growth hormone (GH) secretion in conscious male rabbits: involvement of endogenous GH-releasing factor and somatostatin.
Minamitani N; Chihara K; Kaji H; Kodama H; Kita T; Fujita T
Endocrinology; 1989 Dec; 125(6):2839-45. PubMed ID: 2479528
[TBL] [Abstract][Full Text] [Related]
30. Role of cholinergic muscarinic pathways on the free fatty acid inhibition of GH responses to GHRH in normal men.
Peñalva A; Gaztambide S; Vazquez JA; Dieguez C; Casanueva FF
Clin Endocrinol (Oxf); 1990 Aug; 33(2):171-6. PubMed ID: 2225476
[TBL] [Abstract][Full Text] [Related]
31. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T
Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
[TBL] [Abstract][Full Text] [Related]
32. GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH.
Ross RJ; Tsagarakis S; Grossman A; Nhagafoong L; Touzel RJ; Rees LH; Besser GM
Clin Endocrinol (Oxf); 1987 Dec; 27(6):727-33. PubMed ID: 2901302
[TBL] [Abstract][Full Text] [Related]
33. Effects of alpha- and beta-adrenergic agonists and antagonists on growth hormone secretion in man.
Mazza E; Ghigo E; Bellone J; Arvat E; Revelli E; Cella SG; Brambilla F; Müller EE; Camanni F
Endocrinol Exp; 1990 Mar; 24(1-2):211-9. PubMed ID: 1972919
[TBL] [Abstract][Full Text] [Related]
34. Regulation of Basal and nursing-induced secretion of growth hormone in the neonatal rat: the involvement of serotonergic, muscarinic cholinergic, alpha-adrenergic, somatostatin and growth hormone-releasing hormone systems.
Kacsóh B; Grosvenor CE
J Neuroendocrinol; 1991 Oct; 3(5):529-37. PubMed ID: 19215503
[TBL] [Abstract][Full Text] [Related]
35. Pyridostigmine potentiates growth hormone (GH)-releasing hormone-induced GH release in both men and women.
Arvat E; Cappa M; Casanueva FF; Dieguez C; Ghigo E; Nicolosi M; Valcavi R; Zini M
J Clin Endocrinol Metab; 1993 Feb; 76(2):374-7. PubMed ID: 8432781
[TBL] [Abstract][Full Text] [Related]
36. The role of the cholinergic pathway in growth hormone feedback.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1991 May; 72(5):1081-7. PubMed ID: 1902484
[TBL] [Abstract][Full Text] [Related]
37. Different effects of pyridostigmine on growth hormone (GH) response to GH-releasing hormone in endogenous and exogenous hypercortisolemic patients.
Borges MH; Castro RC; Kater CE; Lengyel AM
Braz J Med Biol Res; 1993 Nov; 26(11):1191-200. PubMed ID: 7907904
[TBL] [Abstract][Full Text] [Related]
38. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli.
Peino R; Cordido F; Peñalva A; Alvarez CV; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1996 Mar; 81(3):909-13. PubMed ID: 8772549
[TBL] [Abstract][Full Text] [Related]
39. [Effect of pre-treatment with pyridostigmine on the stimulation of growth hormone by clonidine and GRF].
Farello G; De Simone M; Gentile T; de Matteis F
Minerva Pediatr; 1991 Oct; 43(10):617-20. PubMed ID: 1758382
[TBL] [Abstract][Full Text] [Related]
40. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity.
Cordido F; Peñalva A; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1993 Apr; 76(4):819-23. PubMed ID: 8473389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
